Rather than representing a specific signature of AD pathophysiology (e.g., Aβ- or tau-mediated mechanisms), these pathways appear to be activated by heterogeneous triggers, including those manipulated in mouse models of HD, ALS, SCA1, and other neurodegenerative disorders. Here, MAPT is linked to amyotrophic lateral sclerosis.